Financial information regarding reportable operating segments |
Summarized financial information regarding our reportable operating segments for the three and six months ended June 30, 2023 and 2022 is shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In millions |
|
|
|
|
|
Components |
|
Engine |
|
Distribution |
|
Power Systems |
|
Accelera |
|
Total Segments |
|
|
|
|
|
Three months ended June 30, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
|
|
|
|
$ |
2,924
|
|
|
$ |
2,263
|
|
|
$ |
2,576
|
|
|
$ |
794
|
|
|
$ |
81
|
|
|
$ |
8,638
|
|
|
|
|
|
|
Intersegment sales |
|
|
|
|
|
501
|
|
|
725
|
|
|
19
|
|
|
663
|
|
|
4
|
|
|
1,912
|
|
|
|
|
|
|
Total sales |
|
|
|
|
|
3,425
|
|
|
2,988
|
|
|
2,595
|
|
|
1,457
|
|
|
85
|
|
|
10,550
|
|
|
|
|
|
|
Research, development and engineering expenses |
|
|
|
|
|
103
|
|
|
148
|
|
|
15
|
|
|
66
|
|
|
52
|
|
|
384
|
|
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
|
|
|
|
24
|
|
|
71
|
|
|
24
|
|
|
18
|
|
|
(4) |
|
|
133
|
|
|
|
|
|
|
Interest income |
|
|
|
|
|
7
|
|
|
7
|
|
|
8
|
|
|
2
|
|
|
1
|
|
|
25
|
|
|
|
|
|
|
Segment EBITDA |
|
|
|
|
|
486
|
|
(1) |
425
|
|
|
299
|
|
|
201
|
|
|
(114) |
|
|
1,297
|
|
|
|
|
|
|
Depreciation and amortization (2)
|
|
|
|
|
|
125
|
|
|
56
|
|
|
28
|
|
|
32
|
|
|
15
|
|
|
256
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended June 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
|
|
|
|
$ |
1,477 |
|
|
$ |
2,092 |
|
|
$ |
2,247 |
|
|
$ |
734 |
|
|
$ |
36 |
|
|
$ |
6,586 |
|
|
|
|
|
|
Intersegment sales |
|
|
|
|
|
473 |
|
|
683 |
|
|
6 |
|
|
469 |
|
|
6 |
|
|
1,637 |
|
|
|
|
|
|
Total sales |
|
|
|
|
|
1,950 |
|
|
2,775 |
|
|
2,253 |
|
|
1,203 |
|
|
42 |
|
|
8,223 |
|
|
|
|
|
|
Research, development and engineering expenses |
|
|
|
|
|
73 |
|
|
116 |
|
|
13 |
|
|
58 |
|
|
39 |
|
|
299 |
|
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
|
|
|
|
9 |
|
|
58 |
|
|
21 |
|
|
10 |
|
|
(3) |
|
|
95 |
|
|
|
|
|
|
Interest income |
|
|
|
|
|
2 |
|
|
1 |
|
|
3 |
|
|
1 |
|
|
— |
|
|
7 |
|
|
|
|
|
|
Russian suspension (recoveries) costs (3)
|
|
|
|
|
|
(2) |
|
|
1 |
|
|
(45) |
|
|
(1) |
|
|
— |
|
|
(47) |
|
|
|
|
|
|
Segment EBITDA |
|
|
|
|
|
352 |
|
|
421 |
|
|
297 |
|
|
128 |
|
|
(79) |
|
|
1,119 |
|
|
|
|
|
|
Depreciation and amortization (2)
|
|
|
|
|
|
49 |
|
|
49 |
|
|
29 |
|
|
31 |
|
|
8 |
|
|
166 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
|
|
|
|
$ |
5,967
|
|
|
$ |
4,515
|
|
|
$ |
4,975
|
|
|
$ |
1,473
|
|
|
$ |
161
|
|
|
$ |
17,091
|
|
|
|
|
|
|
Intersegment sales |
|
|
|
|
|
1,015
|
|
|
1,459
|
|
|
26
|
|
|
1,327
|
|
|
9
|
|
|
3,836
|
|
|
|
|
|
|
Total sales |
|
|
|
|
|
6,982
|
|
|
5,974
|
|
|
5,001
|
|
|
2,800
|
|
|
170
|
|
|
20,927
|
|
|
|
|
|
|
Research, development and engineering expenses |
|
|
|
|
|
194
|
|
|
282
|
|
|
29
|
|
|
129
|
|
|
100
|
|
|
734
|
|
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
|
|
|
|
45
|
|
|
136
|
|
|
48
|
|
|
31
|
|
|
(8) |
|
|
252
|
|
|
|
|
|
|
Interest income |
|
|
|
|
|
13
|
|
|
10
|
|
|
15
|
|
|
4
|
|
|
1
|
|
|
43
|
|
|
|
|
|
|
Segment EBITDA |
|
|
|
|
|
993
|
|
(1) |
882
|
|
|
634
|
|
|
420
|
|
|
(208) |
|
|
2,721
|
|
|
|
|
|
|
Depreciation and amortization (2)
|
|
|
|
|
|
248
|
|
|
107
|
|
|
56
|
|
|
61
|
|
|
29
|
|
|
501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended June 30, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
|
|
|
|
$ |
2,994 |
|
|
$ |
4,141 |
|
|
$ |
4,358 |
|
|
$ |
1,417 |
|
|
$ |
61 |
|
|
$ |
12,971 |
|
|
|
|
|
|
Intersegment sales |
|
|
|
|
|
944 |
|
|
1,387 |
|
|
12 |
|
|
946 |
|
|
12 |
|
|
3,301 |
|
|
|
|
|
|
Total sales |
|
|
|
|
|
3,938 |
|
|
5,528 |
|
|
4,370 |
|
|
2,363 |
|
|
73 |
|
|
16,272 |
|
|
|
|
|
|
Research, development and engineering expenses |
|
|
|
|
|
149 |
|
|
225 |
|
|
26 |
|
|
122 |
|
|
75 |
|
|
597 |
|
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
|
|
|
|
37 |
|
|
100 |
|
(4) |
37 |
|
|
21 |
|
|
(4) |
|
|
191 |
|
|
|
|
|
|
Interest income |
|
|
|
|
|
3 |
|
|
5 |
|
|
5 |
|
|
2 |
|
|
— |
|
|
15 |
|
|
|
|
|
|
Russian suspension costs (3)
|
|
|
|
|
|
4 |
|
|
33 |
|
(5) |
55 |
|
|
19 |
|
|
— |
|
|
111 |
|
|
|
|
|
|
Segment EBITDA |
|
|
|
|
|
672 |
|
|
811 |
|
|
407 |
|
|
218 |
|
|
(144) |
|
|
1,964 |
|
|
|
|
|
|
Depreciation and amortization (2)
|
|
|
|
|
|
92 |
|
|
100 |
|
|
57 |
|
|
62 |
|
|
15 |
|
|
326 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Includes $18 million and $30 million of costs associated with the IPO and separation of Atmus for the three and six months ended June 30, 2023, respectively. See NOTE 15, "FORMATION OF ATMUS AND IPO," to our Condensed Consolidated Financial Statements for additional information.
|
|
|
|
|
|
(2) Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in the Condensed Consolidated Statements of Net Income as interest expense. The amortization of debt discount and deferred costs was $2 million and $2 million for the six months ended June 30, 2023 and June 30, 2022, respectively. A portion of depreciation expense is included in research, development and engineering expenses.
|
|
(3) See NOTE 14, "RUSSIAN OPERATIONS," to our Condensed Consolidated Financial Statements for additional information.
|
|
|
|
|
|
(4) Includes a $28 million impairment of our joint venture with KAMAZ and $3 million of royalty charges as part of our costs associated with the indefinite suspension of our Russian operations. See NOTE 14, "RUSSIAN OPERATIONS," to our Condensed Consolidated Financial Statements for additional information.
|
|
|
|
|
|
(5) Includes $31 million of Russian suspension costs reflected in the equity, royalty and interest income (loss) from investees line above.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of segment information |
A reconciliation of our segment information to the corresponding amounts in the Condensed Consolidated Statements of Net Income is shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
Six months ended |
|
|
June 30, |
|
June 30, |
In millions |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
TOTAL SEGMENT EBITDA |
|
$ |
1,297
|
|
|
$ |
1,119 |
|
|
$ |
2,721
|
|
|
$ |
1,964 |
|
|
|
|
|
|
|
|
|
|
Intersegment eliminations and other (1)
|
|
7
|
|
|
(64) |
|
|
(56) |
|
|
(154) |
|
|
|
|
|
|
|
|
|
|
Less: |
|
|
|
|
|
|
|
|
Interest expense |
|
99
|
|
|
34 |
|
|
186
|
|
|
51 |
|
Depreciation and amortization |
|
256
|
|
|
166 |
|
|
501
|
|
|
326 |
|
INCOME BEFORE INCOME TAXES |
|
$ |
949
|
|
|
$ |
855 |
|
|
1,978
|
|
|
1,433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Intersegment eliminations and other included $5 million and $11 million of costs associated with the IPO and separation of Atmus for the three and six month periods ended June 30, 2023, respectively and $24 million and $41 million for the comparable periods in 2022, respectively. See NOTE 15, "FORMATION OF ATMUS AND IPO," to our Condensed Consolidated Financial Statements for additional information.
|
|
|
|
|
|
|
|
|
|
|